Efficacy of Dihydroartemisinin for Treating Acne Vulgaris
A Pilot Study to Evaluate the Therapeutic Effect of Dihydroartemisinin on Acne Vulgaris
Shanghai Zhongshan Hospital
60 participants
Jun 1, 2025
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to learn if dihydroartemisinin (DHA) works to treat Acne Vulgaris in adults. The main question it aims to answer is: • Does DHA improve the acne severity by at least one grade after treatment. Researchers will treat patients who are clinically diagnosed as Acne Vulgaris to see if DHA works to alleviate the symptoms of Acne Vulgaris. Participants will: * Take DHA every day for 3 months * Visit the clinic once every month for checkups and tests
Eligibility
Inclusion Criteria2
- Clinically diagnosed with acne vulgaris;
- For female patients, no pregnancy plans within the next 6 months.
Exclusion Criteria4
- Patients who have used sex hormones or other systemic medications for acne treatment within the past 3 months;
- Patients who have used topical medications for acne within the past 2 weeks;
- Pregnant or breastfeeding women;
- Patients with known severe diseases of vital organs (e.g., heart, liver, kidney) or malignancies.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DHA 40mg tid for 90 days
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07007078